Home › Compare › ZOM vs NNN

ZOM vs NNN: Dividend Comparison 2026

ZOM yields 2055.50% · NNN yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZOM wins by $12828287195.00M in total portfolio value
10 years
ZOM
ZOM
● Live price
2055.50%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12828287195.01M
Annual income
$11,707,825,857,181,476.00
Full ZOM calculator →
NNN
NNN REIT Inc.
● Live price
5.28%
Share price
$42.80
Annual div
$2.26
5Y div CAGR
2.8%
Payout ratio
71%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$1,147.75
Full NNN calculator →

Portfolio growth — ZOM vs NNN

📍 ZOM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZOMNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZOM + NNN cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ZOM pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZOM
Annual income on $10K today (after 15% tax)
$174,717.37/yr
After 10yr DRIP, annual income (after tax)
$9,951,651,978,604,254.00/yr
NNN
Annual income on $10K today (after 15% tax)
$448.83/yr
After 10yr DRIP, annual income (after tax)
$975.59/yr
At 15% tax rate, ZOM beats the other by $9,951,651,978,603,278.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZOM + NNN for your $10,000?

ZOM: 50%NNN: 50%
100% NNN50/50100% ZOM
Portfolio after 10yr
$6414143597.52M
Annual income
$5,853,912,928,591,312.00/yr
Blended yield
91.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

ZOM
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-0.0
Piotroski
2/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+5.0% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZOM buys
0
NNN buys
0
No recent congressional trades found for ZOM or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZOMNNN
Forward yield2055.50% ✓5.28%
Annual dividend / share$2.00$2.26 ✓
Payout ratio50% ✓71%
1-year div growth0%2.7% ✓
5-year div CAGR0%2.8% ✓
Portfolio after 10y$12828287195.01M ✓$19.7K
Annual income after 10y$11,707,825,857,181,476.00 ✓$1,147.75
Total dividends collected$12748926998.50M ✓$8.1K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: ZOM vs NNN ($10,000, DRIP)

YearZOM PortfolioZOM Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$216,250$205,549.85$10,663$542.82+$205.6K → ZOM
2$4,385,604$4,154,217.05$11,379$587.95+$4.37M → ZOM
3$83,429,631$78,737,034.33$12,153$637.35+$83.42M → ZOM
4$1,489,134,673$1,399,864,967.60$12,990$691.46+$1489.12M → ZOM
5$24,944,940,636$23,351,566,535.79$13,897$750.78+$24944.93M → ZOM
6$392,269,666,568$365,578,580,087.90$14,879$815.88+$392269.65M → ZOM
7$5,792,510,495,062$5,372,781,951,834.12$15,945$887.39+$5792510.48M → ZOM
8$80,345,661,782,925$74,147,675,553,208.94$17,102$965.99+$80345661.77M → ZOM
9$1,047,160,128,816,172$961,190,270,708,442.20$18,360$1,052.49+$1047160128.80M → ZOM
10$12,828,287,195,014,780$11,707,825,857,181,476.00$19,728$1,147.75+$12828287195.00M → ZOM

ZOM vs NNN: Complete Analysis 2026

ZOM — Stock

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Full ZOM Calculator →

NNN — REIT

NNN REIT (formerly National Retail Properties) is a Dividend King with 34+ consecutive years of dividend increases — one of only three REITs to achieve this status. Focuses on single-tenant properties with long-term net leases to operators in necessity-based retail sectors.

Full NNN Calculator →
📬

Get this ZOM vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZOM vs SCHDZOM vs JEPIZOM vs OZOM vs KOZOM vs MAINZOM vs ADCZOM vs EPRTZOM vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.